Clinical Trial Update: Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries [Phase 3]

View source ↗

Summary

A Phase 3 study of vortioxetine (Lu AA21004) for major depressive disorder in Asian countries has completed, with trial results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-10-13